NCT00526357View on ClinicalTrials.gov

Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2012

Conditions
Asthma
Interventions
DRUG

omega-3 fatty acid

Pharmaceutical grade fish oil administered daily in the form of 10 capsules (5 capsules b.i.d.) each containing 400mg of eicosapentaenoic acid (EPA) and 200mg docosahexanoic acid (DHA) which will equate to a daily dose of 4000 mg of EPA and 2000 mg or DHA. The matched placebo containing a 50/50 mix of soybean and corn oil will be supplied by the same manufacturer (Ocean Nutrition, Canada)

Trial Locations (1)

L8N 4A6

Firestone Institute for Respiratory Health, Hamilton

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

Firestone Institute for Respiratory Health

OTHER

NCT00526357 - Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma | Biotech Hunter | Biotech Hunter